Fate Therapeutics Inc

📍 San Diego, United States🗓 Founded 2007👥 320 employees💰 Last funded Jan 2008
Biotechnology Research🌐 fatetherapeutics.com
Website LinkedIn
Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders. Using its proprietary iPSC product platform, the Company has established a leadership position in creating multiplexed-engineered iPSC lines and in the manufacture and clinical development of off-the-shelf, iPSC-derived cell products. The Company’s effector cell pipeline includes multiplexed-engineered, iPSC-derived natural killer (NK) cell and T-cell product candidates, which incorporate novel synthetic controls of cell function, such as chimeric antigen receptors (CARs) to target tumor-associated antigens and are intended to deliver multiple mechanisms of therapeutic importance to patients including in combination with well-established cancer therapies. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit www.fatetherapeutics.com.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2007
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Fate Therapeutics Inc?
Fate Therapeutics Inc has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Fate Therapeutics Inc last raise funding?
The most recent investment in Fate Therapeutics Inc recorded on gritt.io was in January 2008.
When was Fate Therapeutics Inc founded?
Fate Therapeutics Inc was founded in 2007.
What industry is Fate Therapeutics Inc in?
Fate Therapeutics Inc operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Fate Therapeutics Inc based?
Fate Therapeutics Inc is headquartered in San Diego, United States.